Future perspectives of Chinese medical formulae: Chinmedomics as an effector

OMICS A Journal of Integrative Biology

Volumn 16, Issue 7-8, 2012, Pages 414-421

  Wang, Xijun ^a   Zhang, Aihua ^a   Sun, Hui ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID METABOLISM; BIOINFORMATICS; CHEMOMETRICS; CHINESE MEDICINE; CHINMEDOMICS; CLINICAL PRACTICE; ELECTROSPRAY MASS SPECTROMETRY; ENERGY METABOLISM; GAS CHROMATOGRAPHY; GINSENG; HEALTH CARE SYSTEM; HEALTH PROMOTION; HEALTH SERVICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; MASS SPECTROMETRY; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OSTEOLYSIS; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHILOSOPHY; PREVENTIVE MEDICINE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SALVIA MILTIORRHIZA; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUGS, CHINESE HERBAL; HUMANS; INDIVIDUALIZED MEDICINE; MEDICINE, CHINESE TRADITIONAL; METABOLOMICS; MULTIVARIATE ANALYSIS;

EID: 84863895127     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2011.0138     Document Type: Review

References (53)

1. Beckonert, O., Coen, M., Keun, H.C., et al. (2010). High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nat Protoc 5, 1019-1032.
2. Bo, Y., Aihua, Z., Hui, S., et al. (2011). Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquid-chromatography/electrosprayionization synapt high-definition mass spectrometry. J Pharmaceutical Biomedical Anal doi:10.1016/j.jpba.2011.09.033.
3. Chen, R.Q., Wong, C.M., Cao, K.J., and Lam, T.H. (2010). An evidence-based validation of traditional Chinese medicine syndromes. Complement Ther Med 18, 199-205.
4. Gao, X., Zheng, X., Li, Z., et al. (2011). Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry. J Ethnopharmacol 137, 690-699.
5. Geier, F.M., Want, E.J., Leroi, A.M., and Bundy, J.G. (2011). Cross-platform comparison of Caenorhabditis elegans tissue extraction strategies for comprehensive metabolome coverage. Anal Chem 83, 3730-3736.
6. Halama, A., Möller, G., and Adamski, J. (2011). Metabolic signatures in apoptotic human cancer cell lines. OMICS 15, 325-335.
7. Hrydziuszko, O., Silva, M.A., Perera, M.T., et al. (2011). Application of metabolomics to investigate the process of human orthotopic liver transplantation: A proof-of-principle study. OMICS 14, 143-150.
8. Hu, J., Liu, Y.F., Wu, C.F., et al. (2009). Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci USA 106, 3342-3347.
9. Jäger, W., Gruber, A., Giessrigl, B., Krupitza, G., Szekeres, T., and Sonntag, D. (2011). Metabolomic analysis of resveratrolinduced effects in the human breast cancer cell lines MCF-7 and MDA-MB-231. OMICS 15, 9-14.
10. Kim, K., Taylor, S.L., Ganti, S., Guo, L., Osier, M.V., and Weiss, R.H. (2011). Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer. OMICS 15, 293-303.
11. König, S. (2011). Urine molecular profiling distinguishes health and disease: New methods in diagnostics? Focus on UPLC-MS. Expert Rev Mol Diagn 11, 383-391.
12. Kronthaler, J., Gstraunthaler, G., and Heel, C. (2012). Optimizing high-throughput metabolomic biomarker screening: A study of quenching solutions to freeze intracellular metabolism in CHO cells. OMICS 16, 90-97.
13. Liang, X., Chen, X., Liang, Q., et al. (2011). Metabonomic study of Chinese medicine Shuanglong formula as an effective treatment for myocardial infarction in rats. J Proteome Res 10, 790-799.
14. Li, C., Xiao, P., Gray, S.J., Weinberg, M.S., and Samulski, R.J. (2011). Combination therapy utilizing shRNA knockdown and an optimized resistant transgene for rescue of diseases caused by misfolded proteins. Proc Natl Acad Sci USA 108, 14258-14263.
15. Liu, J.Y., Li, N., Yang, J., et al. (2010). Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxibmediated cardiovascular events. Proc Natl Acad Sci USA 107, 17017-17022.
16. Liu, X., Zhang, S., Lu, X., Zheng, S., Li, F., and Xiong, Z. (2012). Metabonomic study on the anti-osteoporosis effect of Rhizoma drynariae and its action mechanism using ultra-performance liquid chromatography-tandem mass spectrometry. J Ethnopharmacol 139, 311-317.
17. Li, X.J., Kong, D.X., and Zhang, H.Y. (2010). Chemoinformatics approaches for traditional Chinese medicine research and case application in anticancer drug discovery. Curr Drug Discov Technol 7, 22-31.
18. Luo, H.G., Chen, J.X., and Yue, G.X. (2008). Metabonomic study on the regulatory effect of xiaoyao powder on chronic immobilization stressed rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 28, 1112-1127.
19. Lu, Y., Liu, X., Liang, X., Xiang, L., and Zhang, W. (2011). Metabolomic strategy to study therapeutic and synergistic effects of tanshinone IIA, salvianolic acid B and ginsenoside Rb1 in myocardial ischemia rats. J Ethnopharmacol 134, 45-49.
20. Lv, Y., Liu, X., Yan, S., et al. (2010). Metabolomic study of myocardial ischemia and intervention effects of Compound Danshen Tablets in rats using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J Pharm Biomed Anal 52, 129-135.
21. Manna, S.K., Patterson, A.D., Yang, Q., et al. (2010). Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse. J Proteome Res 9, 4176-4188.
22. Manna, S.K., Patterson, A.D., Yang, Q., et al. (2011). UPLC-MSbased urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model. J Proteome Res 10, 4120-4133.
23. Nicholson, J.K., and Lindon, J.C. (2008). Systems biology: Metabonomics. Nature 455, 1054-1056.
24. Normile, D. (2003). Asian medicine. The new face of traditional Chinese medicine. Science 299, 188-190.
25. Sreekumar, A., Poisson, L.M., Rajendiran, T.M., et al. (2009). Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910-914.
26. Stone, R. (2008). Biochemistry. Lifting the veil on traditional Chinese medicine. Science 319, 709-710.
27. Sun, H., Ni, B., Zhang, A., Wang, M., Dong, H., and Wang, X. (2012). Metabolomics study on Fuzi and its processed products using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry coupled with pattern recognition analysis. Analyst 137, 170-185.
28. Su, Z.H., Li, S.Q., Zou, G.A., et al. (2011). Urinary metabonomics study of anti-depressive effect of Chaihu-Shu-Gan-San on an experimental model of depression induced by chronic variable stress in rats. J Pharm Biomed Anal 55, 533-539.
29. Tan, G., Lou, Z., Liao, W., et al. (2011). Potential biomarkers in mouse myocardium of doxorubicin-induced cardiomyopathy: A metabonomic method and its application. PLoS One 6, e27683.
30. Twohig, M., Shockcor, J.P., Wilson, I.D., Nicholson, J.K., and Plumb, R.S. (2010). Use of an atmospheric solids analysis probe (ASAP) for high throughput screening of biological fluids: Preliminary applications on urine and bile. J Proteome Res 9, 3590-3597.
31. van Der Greef, J., Martin, S., Juhasz, P., et al. (2007). The art and practice of systems biology in medicine: Mapping patterns of relationships. J Proteome Res 6, 1540-1559.
32. van Der Greef, J., Van Wietmarschen, H., Schroën, J., Wang, M., Hankemeier, T., and Xu, G. (2010). Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western medicine. Planta Med 76, 2036-2047.
33. van Wietmarschen, H., Yuan, K., Lu, C., et al. (2009). Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients. J Clin Rheumatol 15, 330-337.
34. Villas-Bô as, S.G., and Bruheim, P. (2007). The potential of metabolomics tools in bioremediation studies. OMICS 11, 305-313.
35. Wang, E., Bussom, S., Chen, J., et al. (2011c). Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment. BMC Med Genomics 4, 38.
36. Wang, L., Zhou, G.B., Liu, P., et al. (2008a). Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA 105, 4826-4831.
37. Wang,M., Rang,W., Zhang, Q., et al. (2010a). NMR-spectroscopybased metabonomic approach to analysis of Siwutang, a novel prescription, treated blood deficiency in mice. Zhongguo Zhong Yao Za Zhi 35, 630-634.
38. Wang, P., Sun, H., Lv, H., et al. (2010b). Thyroxine and reserpine-induced changes in metabolic profiles of rat urine and the therapeutic effect of Liu Wei Di Huang Wan detected by UPLC-HDMS. J Pharm Biomed Anal 53, 631-645.
39. Wang, X., Lv, H., Sun, H., et al. (2008b). Metabolic urinary profiling of alcohol hepatotoxicity and intervention effects of Yin Chen Hao Tang in rats using ultra-performance liquid chromatography/electrospray ionization quadruple timeof-flight mass spectrometry. J Pharm Biomed Anal 48, 1161-1168.
40. Wang, X., Sun, H., Zhang, A., Sun, W., Wang, P., and Wang, Z. (2011a). Potential role of metabolomics approaches in the area of traditional Chinese medicine: As pillars of the bridge between Chinese and Western medicine. J Pharm Biomed Anal 55, 859-868.
41. Wang, X., Sun, H., Zhang, A., Wang, P., and Han, Y. (2011b). Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies. J Sep Sci doi:10.1002/jssc.201100333.
42. Wang, X., Wang, H., Zhang, A., et al. (2011d). Metabolomics study on the toxicity of aconite root and its processed products using ultraperformance liquid-chromatography/electrosprayionization synapt high-definition mass spectrometry coupled with pattern recognition approach and ingenuity pathways analysis. J Proteome Res 11, 1284-1301.
43. Wang, X., Yang, B., Sun, H., and Zhang, A. (2012). Pattern recognition approaches and computational systems tools for ultra performance liquid chromatography-mass spectrometrybased comprehensive metabolomic profiling and pathways analysis of biological data sets. Anal Chem 84, 428-439.
44. Wang, X., and Zhang, B. (2010). Elucidation of compatibility principle and scientific value of Chinese medical formulae based on pharmacometabolomics. Zhongguo Zhong Yao Za Zhi 35, 1346-1348.
45. Wu, Y., Tao, Y., Liang, L., et al. (2009). Metabonomic profile of rats with acute liver rejection. OMICS 13, 81-91.
46. Xue, T., and Roy, R. (2003). Studying traditional Chinese medicine. Science 300, 740-741.
47. Xie, B., Gong, T., Gao, R., et al. (2009). Development of rat urinary HPLC-UV profiling for metabonomic study on Liuwei Dihuang Pills. J Pharm Biomed Anal 49, 492-497.
48. Yu, H., Li, L., Liang, Q., Wang, Y., Li, P., and Luo, G. (2011). A metabonomic study on the treatment of diabetic nephropathy with traditional Chinese medicine tang-shen-fang. Se Pu 29, 320-324.
49. Zhang, A., Sun, H., Wang, P., Han, Y., and Wang, X. (2012a). Modern analytical techniques in metabolomics analysis. Analyst 137, 293-300.
50. Zhang, A., Sun, H., Wang, P., Han, Y., and Wang, X. (2012b) Future perspectives of personalized medicine in traditional Chinese medicine: A systems biology approach. Complement Ther Med 20, 93-99.
51. Zhang, A., Sun, H., Wang, Z., Sun, W., Wang, P., and Wang, X. (2010). Metabolomics: Towards understanding traditional Chinese medicine. Planta Med 76, 2026-2035.
52. Zhang, A., Sun, H., Yuan, Y., Sun, W., Jiao, G., and Wang, X. (2011). An in vivo analysis of the therapeutic and synergistic properties of Chinese medicinal formula Yin-Chen-Hao-Tang based on its active constituents. Fitoterapia 82, 1160-1168.
53. Zhang, Q.Y., Mao, J.H., Liu, P., et al. (2009). A systems biology understanding of the synergistic effects of arsenic sulfide and imatinib in BCR/ABL-associated leukemia. Proc Natl Acad Sci USA 106, 3378-3383.